Marc Appel

Managing Partner at Pacific Bridge NY

Speaker

Marc Appel, JD, MBA, is an advisor to university innovation programs including Yale’s Blavatnik Program, Cornell’s tech transfer office, and Dartmouth’s Cancer Accelerator. He founded Orange Grove Bio and served as its CEO from 2019 to 2024, also helping launch biotech companies like IpiNovyx Bio and Allonix Therapeutics. Marc was previously a healthcare investor at Marathon Asset Management, Highbridge Principal Strategies, and Eaton Vance, and began his career at McKinsey & Co. He frequently speaks at industry conferences and universities and co-authored a Harvard Business School case on Imprimis Pharmaceuticals. He holds a B.A. from Yale, a J.D. from Harvard Law School, and an M.B.A. from Harvard Business School. He is a member of the New York Bar.